Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH 2017 | Game-changing treatments for leukemia

Ravi Majeti • 12 Oct 2017
ESH 2017
Leukemia

This is an exciting time for leukemia treatment, with multiple new therapies being approved and various agents on the horizon. At the International Conference of Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ravindra Majeti, MD, PhD, from Stanford University, Stanford, CA, discusses why he is enthusiastic about novel treatments against leukemia and details the improvements required to move this treatment forwards.

More from Ravi Majeti

Clonal hematopoiesis, early detection & potential therapeutics
Courtney DiNardo et al. • 4 Sep 2023
1:34
The use of single-cell technologies to dissect AML heterogeneity
Ravi Majeti • 21 Mar 2023
1:49
Targeting leukemic stem cells in AML
Ravi Majeti • 21 Mar 2023
1:12
Using epigenetic analysis to understand the biology of relapse in AML
Ravi Majeti • 21 Mar 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals